Trial intelligence / Profile preview

MINA

NCT06273072Phase 2Recruiting

Sponsor
Johns Hopkins University
Start
Dec 2024
Primary completion
Dec 2026
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of liquid metformin (Aspargo Labs) in asthma, sponsored by Johns Hopkins University. Started Dec 2024; status: recruiting.

02

Drugs

liquid metformin (Aspargo Labs)
03

Conditions

asthma

Beyond the preview

Go deeper on NCT06273072.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT06273072.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call